Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 12, Pages 3989
Publisher
MDPI AG
Online
2020-12-11
DOI
10.3390/jcm9123989
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system
- (2020) Susanne Pfefferle et al. Eurosurveillance
- Diagnostic performances and thresholds: the key to harmonization in serological SARS-CoV-2 assays?
- (2020) Mario Plebani et al. CLINICA CHIMICA ACTA
- Molecular and serological assays for SARS-CoV-2: insights from genome and clinical characteristics
- (2020) Jiping Shi et al. CLINICAL CHEMISTRY
- Validation of a chemiluminescent assay for specific SARS-CoV-2 antibody
- (2020) Marie Tré-Hardy et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein
- (2020) Tahir S Pillay JOURNAL OF CLINICAL PATHOLOGY
- Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures
- (2020) Rachael Pung et al. LANCET
- Connecting clusters of COVID-19: an epidemiological and serological investigation
- (2020) Sarah Ee Fang Yong et al. LANCET INFECTIOUS DISEASES
- The important role of serology for COVID-19 control
- (2020) Amy K Winter et al. LANCET INFECTIOUS DISEASES
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- Report from the American Society for Microbiology COVID-19 International Summit, 23 March 2020: Value of Diagnostic Testing for SARS–CoV-2/COVID-19
- (2020) Robin Patel et al. mBio
- Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19
- (2020) Kimberly E Hanson et al. CLINICAL INFECTIOUS DISEASES
- SARS-CoV-2-specific antibody detection for sero-epidemiology: a multiplex analysis approach accounting for accurate seroprevalence
- (2020) Gerco den Hartog et al. JOURNAL OF INFECTIOUS DISEASES
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2: characteristics and current advances in research
- (2020) Yicheng Yang et al. Virology Journal
- COVID-19 Serological Tests: How Well Do They Actually Perform?
- (2020) Abdi Ghaffari et al. Diagnostics
- Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays
- (2020) Mei San Tang et al. CLINICAL CHEMISTRY
- Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
- (2020) Rita Christiane Baron et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Prevalence of SARS-CoV-2 antibodies among Swiss hospital workers: Results of a prospective cohort study
- (2020) Philipp P. Kohler et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Change in Antibodies to SARS-CoV-2 Over 60 Days Among Health Care Personnel in Nashville, Tennessee
- (2020) Manish M. Patel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2 IgG and IgA antibody response is gender dependent; and IgG antibodies rapidly decline early on
- (2020) Wolfgang Korte et al. JOURNAL OF INFECTION
- Weak correlation between antibody titers and neutralizing activity in sera from SARS‐CoV‐2 infected subjects
- (2020) Elena Criscuolo et al. JOURNAL OF MEDICAL VIROLOGY
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
- (2020) Ariane Sternberg et al. LIFE SCIENCES
- Humoral Immune Response to SARS-CoV-2 in Iceland
- (2020) Daniel F. Gudbjartsson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- A consideration of convalescent plasma and plasma derivatives in the care of Severely-ill patients with COVID-19
- (2020) Thomas Lung et al. TRANSFUSION AND APHERESIS SCIENCE
- Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
- (2020) Guillaume Beaudoin-Bussières et al. mBio
- Covid-19: What’s going wrong with testing in the UK?
- (2020) Jacqui Wise BMJ-British Medical Journal
- Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays
- (2020) Ying Tian et al. Cell Discovery
- EDTA-Anticoagulated Whole Blood for SARS-CoV-2 Antibody Testing by Electrochemiluminescence Immunoassay (ECLIA) and Enzyme-Linked Immunosorbent Assay (ELISA)
- (2020) Marc Kovac et al. Diagnostics
- Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
- (2020) Martin Risch et al. Biomed Research International
- Cigarette smoking differentially affects immunoglobulin class levels in serum and saliva: An investigation and review
- (2019) Nesrin Tarbiah et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection
- (2008) Aline Simen-Kapeu et al. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now